Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis.
To perform a meta-analysis of prospective and retrospective studies exploring the association of the modified Glasgow prognostic score (mGPS) with overall survival (OS) in patients with lung cancer.Relevant studies were identified by searching the Cochrane Library, Web of Science, Embase and PubMed...
Main Authors: | Jing Jin, Kejia Hu, Yongzhao Zhou, Weimin Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5590927?pdf=render |
Similar Items
-
The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis
by: Huan Zhang, et al.
Published: (2020-09-01) -
A Meta-Analysis of Glasgow Prognostic Score and Modified Glasgow Prognostic Score as Biomarkers for Predicting Survival Outcome in Renal Cell Carcinoma
by: Tongyu Tong, et al.
Published: (2020-09-01) -
Prognostic Value of the Glasgow Prognostic Score or Modified Glasgow Prognostic Score for Patients with Colorectal Cancer Receiving Various Treatments: a Systematic Review and Meta-Analysis
by: Liying He, et al.
Published: (2018-11-01) -
Utility of the High-Sensitivity Modified Glasgow Prognostic Scores for Oropharyngeal Carcinoma
by: Hiroyuki Iuchi MD, PhD, et al.
Published: (2021-09-01) -
Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Pancreatic Cancer: A Meta-Analysis
by: Wen Fu, et al.
Published: (2020-07-01)